Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

Mesabi Trust (MSB) Financials

Mesabi Trust logo
$25.55 +0.09 (+0.35%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$25.52 -0.03 (-0.13%)
As of 05/22/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Mesabi Trust

Annual Income Statements for Mesabi Trust

This table shows Mesabi Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 69 5.31 19 93
Consolidated Net Income / (Loss)		 69 5.31 19 93
Net Income / (Loss) Continuing Operations		 69 5.31 19 93
Total Pre-Tax Income 		69 5.31 19 93
Total Operating Income		 69 5.31 19 93
Total Gross Profit		 71 7.35 23 98
Total Revenue		 71 7.74 23 99
Operating Revenue		 71 7.74 23 99
Total Cost of Revenue		 0.35 0.39 0.32 0.32
Operating Cost of Revenue		 0.29 0.33 0.26 0.26
Other Cost of Revenue		 0.06 0.06 0.06 0.06
Total Operating Expenses		 2.34 2.04 3.56 5.00
Selling, General & Admin Expense		 0.05 0.05 0.33 0.50
Other Operating Expenses / (Income)		 0.56 0.61 0.66 0.65
Other Special Charges / (Income)		 1.73 1.37 2.57 3.85
Total Other Income / (Expense), net		 0.00 0.00 0.00 0.00
Basic Earnings per Share		 $5.24 $0.41 $1.45 $7.11
Weighted Average Basic Shares Outstanding		 13.12M 13.12M 13.12M 13.12M
Weighted Average Diluted Shares Outstanding		 13.12M 13.12M 13.12M 13.12M
Weighted Average Basic & Diluted Shares Outstanding		 13.12M 13.12M 13.12M 13.12M

Quarterly Income Statements for Mesabi Trust

This table shows Mesabi Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 7/31/2022 10/31/2022 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Consolidated Net Income / (Loss)		 -4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Net Income / (Loss) Continuing Operations		 -4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 79 5.60
Total Pre-Tax Income 		-4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 79 5.60
Total Operating Income		 -4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Total Gross Profit		 -4.86 -0.41 -0.98 1.02 9.18 4.09 8.25 3.48 5.40 78 11
Total Revenue		 -4.37 0.08 -2.17 1.85 9.89 4.90 6.23 6.25 6.49 79 6.85
Operating Revenue		 -4.37 0.08 -2.17 1.85 9.89 4.90 6.23 6.25 6.49 79 6.85
Total Cost of Revenue		 0.49 0.50 -1.20 0.83 0.71 0.81 -2.02 2.77 1.09 0.68 -4.22
Operating Cost of Revenue		 0.49 0.50 -1.26 0.83 0.71 0.81 -2.08 2.77 1.09 0.68 -4.28
Total Operating Expenses		 0.00 0.00 2.04 0.00 0.00 0.00 3.56 0.00 0.00 0.00 5.00
Total Other Income / (Expense), net		 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.47 -0.47
Basic Earnings per Share		 ($0.37) ($0.03) ($0.23) $0.08 $0.70 $0.31 $0.36 $0.27 $0.41 $5.97 $0.46
Weighted Average Basic Shares Outstanding		 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Weighted Average Diluted Shares Outstanding		 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Weighted Average Basic & Diluted Shares Outstanding		 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M

Annual Cash Flow Statements for Mesabi Trust

This table details how cash moves in and out of Mesabi Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Net Change in Cash & Equivalents		 35 -34 10 76
Net Cash From Operating Activities		 63 14 15 94
Net Cash From Continuing Operating Activities		 63 14 15 94
Net Income / (Loss) Continuing Operations		 69 5.31 19 93
Consolidated Net Income / (Loss)		 69 5.31 19 93
Non-Cash Adjustments To Reconcile Net Income		 -1.25 1.43 -0.45 0.21
Changes in Operating Assets and Liabilities, net		 -4.67 7.12 -3.93 0.45
Net Cash From Investing Activities		 9.91 0.00 0.00 0.00
Net Cash From Continuing Investing Activities		 9.91 0.00 0.00 0.00
Net Cash From Financing Activities		 -38 -48 -4.59 -18
Net Cash From Continuing Financing Activities		 -38 -48 -4.59 -18
Payment of Dividends		 -38 -48 -4.59 -18

Quarterly Cash Flow Statements for Mesabi Trust

This table details how cash moves in and out of Mesabi Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 7/31/2022 10/31/2022 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025
Net Change in Cash & Equivalents		 -35 12 -0.54 -0.86 4.65 5.16 1.07 -2.35 0.00 74 4.29
Net Cash From Operating Activities		 1.57 -0.26 -0.54 -0.86 4.65 5.16 5.66 2.50 3.81 78 9.41
Net Cash From Continuing Operating Activities		 1.57 -0.26 -0.54 -0.86 4.65 5.16 5.66 2.50 3.81 78 9.41
Net Income / (Loss) Continuing Operations		 -4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Consolidated Net Income / (Loss)		 -4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Non-Cash Adjustments To Reconcile Net Income		 4.40 - - 0.00 -2.03 1.03 0.55 -1.11 -0.18 1.07 0.43
Changes in Operating Assets and Liabilities, net		 2.02 0.15 2.48 -1.89 -2.50 0.04 0.42 0.13 -1.41 -1.18 2.92
Net Cash From Financing Activities		 -14 -11 - 0.00 - - -4.59 -4.85 -3.80 -3.94 -5.12
Net Cash From Continuing Financing Activities		 -14 -11 - 0.00 - - -4.59 -4.85 -3.80 -3.94 -5.12
Payment of Dividends		 -14 -11 - 0.00 - - -4.59 -4.85 -3.80 -3.94 -5.12

Annual Balance Sheets for Mesabi Trust

This table presents Mesabi Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Total Assets		 54 14 27 102
Total Current Assets		 54 14 27 102
Cash & Equivalents		 48 14 24 100
Accounts Receivable		 4.63 0.02 1.96 1.16
Prepaid Expenses		 0.12 0.13 0.30 0.12
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00
Plant, Property & Equipment, gross		 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity		 54 14 27 102
Total Liabilities		 23 2.68 5.72 78
Total Current Liabilities		 23 0.38 5.72 78
Accrued Expenses		 0.16 0.38 0.86 0.34
Dividends Payable		 23 0.00 4.85 78
Total Noncurrent Liabilities		 0.00 2.30 0.00 0.00
Other Noncurrent Operating Liabilities		 0.00 2.30 0.00 0.00
Total Equity & Noncontrolling Interests		 31 11 21 23
Total Preferred & Common Equity		 31 11 21 23
Total Common Equity		 31 11 21 23
Other Equity Adjustments		 31 11 21 23

Quarterly Balance Sheets for Mesabi Trust

This table presents Mesabi Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 4/30/2022 7/31/2022 10/31/2022 4/30/2023 7/31/2023 10/31/2023 4/30/2024 7/31/2024 10/31/2024
Total Assets		 45 26 15 15 22 26 25 26 101
Total Current Assets		 45 26 15 15 22 26 25 26 101
Cash & Equivalents		 38 2.45 15 13 18 23 22 22 96
Accounts Receivable		 2.31 0.01 0.03 1.39 1.81 1.89 1.83 2.58 3.88
Prepaid Expenses		 0.11 0.30 0.21 0.11 0.30 0.21 0.11 0.29 0.20
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Plant, Property & Equipment, gross		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity		 45 26 15 15 22 26 25 26 101
Total Liabilities		 14 11 0.30 2.14 0.26 4.87 4.48 4.13 5.34
Total Current Liabilities		 14 11 0.30 0.22 0.26 4.87 4.48 4.13 5.34
Accrued Expenses		 0.30 0.21 0.30 0.22 0.26 0.28 0.67 0.20 0.23
Dividends Payable		 14 11 0.00 - - 4.59 3.80 3.94 5.12
Total Noncurrent Liabilities		 0.00 0.00 0.00 1.93 0.00 0.00 0.00 0.00 0.00
Other Noncurrent Operating Liabilities		 - 0.00 - 1.93 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 31 15 14 12 22 21 21 22 95
Total Preferred & Common Equity		 31 15 14 12 22 21 21 22 95
Total Common Equity		 31 15 14 12 22 21 21 22 95
Other Equity Adjustments		 31 15 14 12 22 21 21 22 95

Annual Metrics And Ratios for Mesabi Trust

This table displays calculated financial ratios and metrics derived from Mesabi Trust's official financial filings.

Metric 2022 2023 2024 2025
Period end date 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Growth Metrics		 - - - -
Revenue Growth		 175.37% -89.17% 195.30% 331.26%
EBITDA Growth		 193.77% -92.28% 257.56% 391.35%
EBIT Growth		 193.77% -92.28% 257.56% 391.35%
NOPAT Growth		 193.77% -92.28% 257.56% 391.35%
Net Income Growth		 193.77% -92.28% 257.56% 391.35%
EPS Growth		 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 202.02% -77.94% 5.35% 543.14%
Free Cash Flow Firm Growth		 202.02% -77.94% 8.61% 522.43%
Invested Capital Growth		 5,659.93% -141.95% 155.26% -32.25%
Revenue Q/Q Growth		 11.08% -72.22% 58.08% 0.64%
EBITDA Q/Q Growth		 12.15% -79.40% 68.33% 1.50%
EBIT Q/Q Growth		 12.15% -79.40% 68.33% 1.50%
NOPAT Q/Q Growth		 12.15% -79.40% 68.33% 1.50%
Net Income Q/Q Growth		 12.15% -79.40% 68.33% 1.50%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 16.22% -60.27% 73.71% 4.16%
Free Cash Flow Firm Q/Q Growth		 16.22% -60.27% 60.02% 4.31%
Invested Capital Q/Q Growth		 -33.64% -4,829.87% -23.06% -75.49%
Profitability Metrics		 - - - -
Gross Margin		 99.51% 94.90% 98.60% 99.68%
EBITDA Margin		 96.23% 68.58% 83.03% 94.60%
Operating Margin		 96.23% 68.58% 83.03% 94.60%
EBIT Margin		 96.23% 68.58% 83.03% 94.60%
Profit (Net Income) Margin		 96.23% 68.58% 83.03% 94.60%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 2,242.89% 303.47% 0.00% 7,959.21%
ROIC Less NNEP Spread (ROIC-NNEP)		 2,242.89% 303.47% 0.00% 7,959.21%
Return on Net Nonoperating Assets (RNNOA)		 -1,951.95% -278.32% 0.00% -7,538.13%
Return on Equity (ROE)		 290.94% 25.14% 117.13% 421.08%
Cash Return on Invested Capital (CROIC)		 2,049.72% 0.00% 1,077.71% 7,997.66%
Operating Return on Assets (OROA)		 178.98% 15.61% 93.04% 145.27%
Return on Assets (ROA)		 178.98% 15.61% 93.04% 145.27%
Return on Common Equity (ROCE)		 290.94% 25.14% 117.13% 421.08%
Return on Equity Simple (ROE_SIMPLE)		 223.30% 46.42% 90.50% 399.84%
Net Operating Profit after Tax (NOPAT)		 69 5.31 19 93
NOPAT Margin		 96.23% 68.58% 83.03% 94.60%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 - - - 399.84%
Cost of Revenue to Revenue		 0.49% 5.10% 1.40% 0.32%
SG&A Expenses to Revenue		 0.07% 0.68% 1.44% 0.51%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 3.28% 26.32% 15.57% 5.07%
Earnings before Interest and Taxes (EBIT)		 69 5.31 19 93
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 69 5.31 19 93
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 10.73 25.50 12.20 13.27
Price to Tangible Book Value (P/TBV)		 10.73 25.50 12.20 13.27
Price to Revenue (P/Rev)		 4.62 37.67 11.20 3.14
Price to Earnings (P/E)		 4.81 54.93 13.48 3.32
Dividend Yield		 16.48% 22.72% 3.69% 29.36%
Earnings Yield		 20.81% 1.82% 7.42% 30.12%
Enterprise Value to Invested Capital (EV/IC)		 46.91 0.00 166.04 221.24
Enterprise Value to Revenue (EV/Rev)		 3.96 35.87 10.15 2.12
Enterprise Value to EBITDA (EV/EBITDA)		 4.11 52.30 12.22 2.25
Enterprise Value to EBIT (EV/EBIT)		 4.11 52.30 12.22 2.25
Enterprise Value to NOPAT (EV/NOPAT)		 4.11 52.30 12.22 2.25
Enterprise Value to Operating Cash Flow (EV/OCF)		 4.50 20.03 15.88 2.23
Enterprise Value to Free Cash Flow (EV/FCFF)		 4.50 20.03 15.41 2.23
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00
Financial Leverage		 -0.87 -0.92 -1.03 -0.95
Leverage Ratio		 1.63 1.61 1.26 2.90
Compound Leverage Factor		 1.63 1.61 1.26 2.90
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00
Altman Z-Score		 14.80 68.27 31.02 6.64
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - -
Current Ratio		 2.33 37.06 4.67 1.30
Quick Ratio		 2.26 36.72 4.54 1.29
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 63 14 15 94
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - -
Asset Turnover		 1.86 0.23 1.12 1.54
Accounts Receivable Turnover		 29.28 3.33 23.05 63.18
Inventory Turnover		 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 23,819,930.00 2,580,658.00 7,620,676.33 32,865,217.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 12.47 109.73 15.84 5.78
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 12.47 109.73 15.84 5.78
Capital & Investment Metrics		 - - - -
Invested Capital		 6.03 -2.53 1.40 0.95
Invested Capital Turnover		 23.31 4.43 -40.43 84.13
Increase / (Decrease) in Invested Capital		 5.92 -8.56 3.93 -0.45
Enterprise Value (EV)		 283 278 232 209
Market Capitalization		 330 292 256 310
Book Value per Share		 $2.35 $0.87 $1.60 $1.78
Tangible Book Value per Share		 $2.35 $0.87 $1.60 $1.78
Total Capital		 31 11 21 23
Total Debt		 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00
Net Debt		 -48 -14 -24 -100
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -17 -0.23 -3.01 -77
Debt-free Net Working Capital (DFNWC)		 31 14 21 23
Net Working Capital (NWC)		 31 14 21 23
Net Nonoperating Expense (NNE)		 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)		 -25 -14 -20 -22
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 -23.70% -2.97% -13.15% -77.97%
Debt-free Net Working Capital to Revenue		 43.09% 177.43% 91.75% 23.66%
Net Working Capital to Revenue		 43.09% 177.43% 91.75% 23.66%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $5.24 $0.41 $1.45 $7.11
Adjusted Weighted Average Basic Shares Outstanding		 13.12M 13.12M 13.12M 13.12M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 13.12M 13.12M 13.12M 13.12M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.12M 13.12M 13.12M 13.12M
Normalized Net Operating Profit after Tax (NOPAT)		 49 4.68 15 68
Normalized NOPAT Margin		 69.05% 60.41% 66.00% 68.96%
Pre Tax Income Margin		 96.23% 68.58% 83.03% 94.60%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Payout Ratios		 - - - -
Dividend Payout Ratio		 54.57% 897.06% 24.19% 18.99%
Augmented Payout Ratio		 54.57% 897.06% 24.19% 18.99%

Quarterly Metrics And Ratios for Mesabi Trust

This table displays calculated financial ratios and metrics derived from Mesabi Trust's official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 7/31/2022 10/31/2022 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -115.74% -99.48% -112.10% -86.98% 326.46% 5,681.78% 386.72% 238.08% -34.37% 1,513.58% 10.04%
EBITDA Growth		 -118.15% -102.59% -117.29% -92.47% 289.06% 1,087.71% 255.58% 240.50% -41.22% 1,816.89% 29.34%
EBIT Growth		 -118.15% -102.59% -117.29% -92.47% 289.06% 1,087.71% 255.58% 240.50% -41.22% 1,816.89% 29.34%
NOPAT Growth		 -112.71% -101.81% -112.10% -92.47% 370.09% 1,511.01% 322.26% 240.50% -41.22% 1,816.89% 29.34%
Net Income Growth		 -118.15% -102.59% -117.29% -92.47% 289.06% 1,087.71% 255.58% 240.50% -41.22% 1,816.89% 29.34%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 -91.41% -101.41% -102.62% -106.59% 196.37% 2,053.76% 1,151.92% 389.93% -18.12% 1,415.26% 66.28%
Free Cash Flow Firm Growth		 -51.35% 1.07% -44.06% -21.21% -10.82% -74.91% -88.13% -80.79% -38.32% 3,337.82% 751.64%
Invested Capital Growth		 -99.17% -100.56% -141.95% -109.83% 1,794.09% 3,640.90% 155.26% 297.81% 44.11% 112.68% -32.25%
Revenue Q/Q Growth		 -130.76% 101.94% -2,665.09% 185.12% 434.89% -50.49% 27.20% 0.36% 3.83% 1,117.30% -91.33%
EBITDA Q/Q Growth		 -135.73% 91.48% -628.81% 133.93% 797.57% -55.51% 14.80% -25.73% 54.94% 1,351.04% -92.25%
EBIT Q/Q Growth		 -135.73% 91.48% -628.81% 133.93% 797.57% -55.51% 14.80% -25.73% 54.94% 1,351.04% -92.25%
NOPAT Q/Q Growth		 -125.01% 91.48% -628.81% 148.48% 797.57% -55.51% 14.80% -25.73% 54.94% 1,351.04% -92.25%
Net Income Q/Q Growth		 -135.73% 91.48% -628.81% 133.93% 797.57% -55.51% 14.80% -25.73% 54.94% 1,351.04% -92.25%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 -88.03% -116.85% -103.65% -60.52% 638.19% 11.05% 9.65% -55.76% 52.00% 1,955.07% -87.97%
Free Cash Flow Firm Q/Q Growth		 -19.93% 6.28% -27.13% 27.05% -9.37% -70.10% -65.51% 105.58% 190.94% 1,566.45% -91.46%
Invested Capital Q/Q Growth		 -98.49% -152.22% -4,829.87% 74.63% 389.96% -2.37% -23.06% -9.18% 111.24% 44.07% -75.49%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% -488.53% 0.00% 55.34% 92.86% 83.46% 132.47% 55.74% 83.17% 99.14% 161.52%
EBITDA Margin		 0.00% -488.53% 0.00% 55.34% 92.86% 83.46% 75.32% 55.74% 83.17% 99.14% 88.53%
Operating Margin		 0.00% -488.53% 0.00% 55.34% 92.86% 83.46% 75.32% 55.74% 83.17% 99.14% 88.53%
EBIT Margin		 0.00% -488.53% 0.00% 55.34% 92.86% 83.46% 75.32% 55.74% 83.17% 99.14% 88.53%
Profit (Net Income) Margin		 0.00% -488.53% 0.00% 55.34% 92.86% 83.46% 75.32% 55.74% 83.17% 99.14% 88.53%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 99.41% 108.37%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.60% 92.28%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -2,110.58% 0.00% 0.00% 915.25% 1,367.90% 0.00% 4,843.35% 874.25% 3,421.29% 7,448.02%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -2,109.99% 0.00% 0.00% 915.25% 1,367.90% 0.00% 4,843.35% 874.25% 3,421.29% 7,448.02%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 1,734.63% 0.00% 0.00% -866.16% -1,300.08% 0.00% -4,751.58% -783.54% -3,254.49% -7,053.99%
Return on Equity (ROE)		 0.00% -375.96% 0.00% -33.62% 49.09% 67.82% 117.13% 91.77% 90.72% 166.80% 394.03%
Cash Return on Invested Capital (CROIC)		 904.42% 0.00% 0.00% 0.00% 512.26% 518.20% 1,077.71% 1,539.30% 741.64% 3,164.88% 7,997.66%
Operating Return on Assets (OROA)		 0.00% -389.80% 0.00% 0.00% 37.34% 59.22% 84.39% 76.49% 82.45% 153.35% 135.94%
Return on Assets (ROA)		 0.00% -389.80% 0.00% 0.00% 37.34% 59.22% 84.39% 76.49% 82.45% 153.35% 135.94%
Return on Common Equity (ROCE)		 0.00% -375.96% 0.00% -33.62% 49.09% 67.82% 117.13% 91.77% 90.72% 166.80% 394.03%
Return on Equity Simple (ROE_SIMPLE)		 283.67% 178.28% 0.00% -58.28% 31.31% 53.35% 0.00% 103.82% 79.85% 96.41% 0.00%
Net Operating Profit after Tax (NOPAT)		 -3.40 -0.29 -2.11 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
NOPAT Margin		 0.00% -341.97% 0.00% 55.34% 92.86% 83.46% 75.32% 55.74% 83.17% 99.14% 88.53%
Net Nonoperating Expense Percent (NNEP)		 -6.96% -0.59% -4.67% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - 19.33% - - - 82.17% 26.01%
Cost of Revenue to Revenue		 0.00% 588.53% 0.00% 44.66% 7.14% 16.54% -32.47% 44.26% 16.83% 0.86% -61.52%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 57.15% 0.00% 0.00% 0.00% 72.99%
Earnings before Interest and Taxes (EBIT)		 -4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -4.86 -0.41 -3.02 1.02 9.18 4.09 4.69 3.48 5.40 78 6.07
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 23.23 19.52 25.50 23.19 11.12 11.86 12.20 10.21 10.43 3.32 13.27
Price to Tangible Book Value (P/TBV)		 23.23 19.52 25.50 23.19 11.12 11.86 12.20 10.21 10.43 3.32 13.27
Price to Revenue (P/Rev)		 7.82 10.12 37.67 0.00 24.93 17.33 11.20 7.74 9.67 3.23 3.14
Price to Earnings (P/E)		 8.19 10.95 54.93 0.00 35.50 22.23 13.48 9.84 13.06 3.44 3.32
Dividend Yield		 19.19% 23.48% 22.72% 22.93% 0.00% 1.83% 3.69% 6.28% 7.45% 5.60% 29.36%
Earnings Yield		 12.21% 9.13% 1.82% 0.00% 2.82% 4.50% 7.42% 10.16% 7.66% 29.04% 30.12%
Enterprise Value to Invested Capital (EV/IC)		 3,253.87 0.00 0.00 0.00 119.81 125.43 166.04 149.21 77.97 57.10 221.24
Enterprise Value to Revenue (EV/Rev)		 7.24 9.60 35.87 0.00 23.09 15.75 10.15 6.94 8.76 2.25 2.12
Enterprise Value to EBITDA (EV/EBITDA)		 7.58 10.39 52.30 0.00 32.88 20.20 12.22 8.83 11.84 2.40 2.25
Enterprise Value to EBIT (EV/EBIT)		 7.58 10.39 52.30 0.00 32.88 20.20 12.22 8.83 11.84 2.40 2.25
Enterprise Value to NOPAT (EV/NOPAT)		 7.58 10.39 52.30 0.00 32.88 20.20 12.22 8.83 11.84 2.40 2.25
Enterprise Value to Operating Cash Flow (EV/OCF)		 5.93 7.67 20.03 0.00 74.73 27.09 15.88 10.53 12.20 2.45 2.23
Enterprise Value to Free Cash Flow (EV/FCFF)		 5.93 7.67 20.03 132.56 44.43 24.20 15.41 9.69 12.41 2.45 2.23
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.78 -0.82 -0.92 -0.86 -0.95 -0.95 -1.03 -0.98 -0.90 -0.95 -0.95
Leverage Ratio		 1.25 1.38 1.61 1.37 1.31 1.15 1.26 1.20 1.10 1.09 2.90
Compound Leverage Factor		 1.25 1.38 1.61 1.37 1.31 1.15 1.26 1.20 1.10 1.09 2.67
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 20.21 574.77 66.33 82.06 565.99 32.91 29.25 30.80 36.09 40.22 3.81
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.32 49.82 37.06 67.77 85.41 5.34 4.67 5.61 6.35 18.84 1.30
Quick Ratio		 2.30 49.11 36.72 67.25 76.29 5.09 4.54 5.24 5.86 18.68 1.29
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 8.32 8.84 6.45 8.19 7.42 2.22 0.77 1.57 4.58 76 6.52
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.31 0.80 0.23 0.00 0.40 0.71 1.12 1.37 0.99 1.55 1.54
Accounts Receivable Turnover		 6.98 6.54 3.33 0.00 10.59 15.07 23.05 16.95 10.85 33.97 63.18
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 14,714,120.33 9,289,611.67 2,580,658.00 0.00 3,216,875.67 4,820,670.67 7,620,676.33 9,087,917.33 7,954,806.67 32,656,731.33 32,865,217.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 52.28 55.83 109.73 0.00 34.46 24.23 15.84 21.53 33.63 10.75 5.78
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 52.28 55.83 109.73 0.00 34.46 24.23 15.84 21.53 33.63 10.75 5.78
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.10 -0.05 -2.53 -0.64 1.86 1.82 1.40 1.27 2.68 3.86 0.95
Invested Capital Turnover		 7.41 6.17 4.43 0.00 9.86 16.39 -40.43 86.90 10.51 34.51 84.13
Increase / (Decrease) in Invested Capital		 -12 -9.13 -8.56 -7.17 1.76 1.87 3.93 1.91 0.82 2.05 -0.45
Enterprise Value (EV)		 320 268 278 276 223 228 232 189 209 221 209
Market Capitalization		 345 282 292 289 241 251 256 211 231 316 310
Book Value per Share		 $1.13 $1.10 $0.87 $0.95 $1.65 $1.61 $1.60 $1.57 $1.69 $7.27 $1.78
Tangible Book Value per Share		 $1.13 $1.10 $0.87 $0.95 $1.65 $1.61 $1.60 $1.57 $1.69 $7.27 $1.78
Total Capital		 15 14 11 12 22 21 21 21 22 95 23
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -26 -15 -14 -13 -18 -23 -24 -22 -22 -96 -100
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -11 -0.05 -0.23 1.28 3.89 -1.77 -3.01 -0.98 0.48 -0.59 -77
Debt-free Net Working Capital (DFNWC)		 15 14 14 14 22 21 21 21 22 95 23
Net Working Capital (NWC)		 15 14 14 14 22 21 21 21 22 95 23
Net Nonoperating Expense (NNE)		 1.46 0.12 0.90 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)		 -15 -15 -14 -13 -20 -19 -20 -19 -19 -91 -22
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 -24.74% -0.18% -2.97% 0.00% 40.35% -12.27% -13.15% -3.58% 2.03% -0.60% -77.97%
Debt-free Net Working Capital to Revenue		 33.68% 51.86% 177.43% 0.00% 224.28% 146.17% 91.75% 75.76% 92.67% 97.30% 23.66%
Net Working Capital to Revenue		 33.68% 51.86% 177.43% 0.00% 224.28% 146.17% 91.75% 75.76% 92.67% 97.30% 23.66%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.37) ($0.03) ($0.23) $0.08 $0.70 $0.31 $0.36 $0.27 $0.41 $5.97 $0.46
Adjusted Weighted Average Basic Shares Outstanding		 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Normalized Net Operating Profit after Tax (NOPAT)		 -3.40 -0.29 -2.11 0.72 6.43 2.86 3.28 2.44 3.78 55 4.25
Normalized NOPAT Margin		 0.00% -341.97% 0.00% 38.74% 65.00% 58.42% 52.72% 39.01% 58.22% 69.40% 61.97%
Pre Tax Income Margin		 0.00% -488.53% 0.00% 55.34% 92.86% 83.46% 75.32% 55.74% 83.17% 99.74% 81.69%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 133.77% 257.13% 897.06% -339.61% 162.60% 0.00% 24.19% 44.05% 75.04% 18.70% 18.99%
Augmented Payout Ratio		 133.77% 257.13% 897.06% -339.61% 162.60% 0.00% 24.19% 44.05% 75.04% 18.70% 18.99%

Financials Breakdown Chart

Key Financial Trends

Below are the key trends for Mesabi Trust (NYSE: MSB) based on the quarterly statements provided for the last four years. The focus is on cash flow, earnings, and balance-sheet health, with an eye toward how these trends could affect a retail investor.

  • Strong Q3 2025 profitability and cash generation: Net income (attributable to common shareholders) reached about $78.8 million, with basic earnings per share near $5.97, and operating cash flow from continuing activities around $78.2 million. This marks a period of outsized profitability and cash generation.
  • Significant liquidity buildup by mid-2025: The company’s cash & equivalents grew to approximately $95.9 million by Q3 2025, up from roughly $21.6 million at the start of the year, signaling ample liquidity.
  • Positive balance-sheet posture (low leverage): As of Q3 2025, Total Liabilities were about $5.34 million, while Total Equity was about $95.32 million, implying a very conservatively levered balance sheet with a large equity cushion.
  • Dividend flexibility evident in 2025: Cash dividends per share were set at 0.39 in Q3 2025 and remained 0.39 in Q4 2025, with Q2 2025 at 0.30. This suggests a payout policy supportive of income-focused investors, supported by strong quarterly cash flow in mid-2025.
  • Revenue and gross profits show a near-term peak in Q3 2025: Reported operating revenue in Q3 2025 was about $78.0 million, with substantial gross profit figures indicating strong royalty income during that quarter.
  • Extreme quarterly volatility observed in 2025: Revenue and earnings swing dramatically from Q3 2025 to Q4 2025 (for example, revenue around $78.0M in Q3 vs about $6.85M in Q4; net income likewise swings), suggesting seasonality or one-off timing effects rather than a steady, predictable run-rate.
  • Historical restatements noted in earlier years: Several earlier periods (e.g., restatements in Q3 2024 and Q2 2024) indicate revisions to reported figures, which can complicate long-run comparability for investors focusing on trend lines.
  • Q4 2025 deterioration vs Q3 2025: Net income dropped from roughly $78.8 million in Q3 2025 to about $6.1 million in Q4 2025, with basic EPS down to around $0.46. This sharp quarterly decline highlights earnings volatility and adds risk to near-term outlooks.
  • Cash-flow from operations weakened in the latest quarter: Net cash from continuing operating activities declined from roughly $78.2 million (Q3 2025) to about $9.4 million (Q4 2025), signaling softer ongoing cash generation in the most recent quarter.

Takeaways for investors:

MSB showed a period of exceptionally strong profitability and liquidity in mid-2025, underpinned by a robust balance sheet with very low liabilities relative to equity. However, the pronounced quarter-to-quarter volatility (especially the drop in Q4 2025) underscores earnings risk and potential seasonality in Mesabi’s royalty-related cash flows. Dividend policy appears favorable and supported by the cash generation in peak periods, but investors should assess whether the mid-2025 strength can be sustained over a full year or across multiple years before relying on a steady income stream.

05/25/26 10:38 PM ETAI Generated. May Contain Errors.

Mesabi Trust Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Mesabi Trust's fiscal year ends in January. Their fiscal year 2025 ended on January 31, 2025.

Mesabi Trust's net income appears to be on an upward trend, with a most recent value of $93.27 million in 2025, rising from $68.77 million in 2022. The previous period was $18.98 million in 2024. Check out Mesabi Trust's forecast to explore projected trends and price targets.

Mesabi Trust's total operating income in 2025 was $93.27 million, based on the following breakdown:
  • Total Gross Profit: $98.28 million
  • Total Operating Expenses: $5.00 million

Over the last 3 years, Mesabi Trust's total revenue changed from $71.46 million in 2022 to $98.60 million in 2025, a change of 38.0%.

Mesabi Trust's total liabilities were at $78.40 million at the end of 2025, a 1,271.8% increase from 2024, and a 239.1% increase since 2022.

In the past 3 years, Mesabi Trust's cash and equivalents has ranged from $13.97 million in 2023 to $100.20 million in 2025, and is currently $100.20 million as of their latest financial filing in 2025.

Over the last 3 years, Mesabi Trust's book value per share changed from 2.35 in 2022 to 1.78 in 2025, a change of -24.3%.


Related Companies

Financial statements for NYSE:MSB last updated on 4/26/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel